finasteride
Ligand Summary
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
UNII: 57GNO57U7G
PubChem: 57363
Guide to Pharmacology: 6818
ChEMBL: CHEMBL710
DrugCentral: 1171
LyCHI: NMC5ZNMQ7URT
Target Activities
SRD5A2
3-oxo-5-alpha-steroid 4-dehydrogenase 2
30 Activities
Items per page:
1 – 10 of 30
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 7.84 | |||||
IC50 | 9.74 | J. Med. Chem., (1993) 36:26:4313 | ||||
IC50 | 9.74 | J. Med. Chem., (1997) 40:9:1293 | ||||
IC50 | 9.74 | J. Med. Chem., (1994) 37:15:2352 | ||||
IC50 | 9.74 | J. Med. Chem., (1995) 38:14:2621 | ||||
IC50 | 9.74 | J Med Chem, (2018) 61:14:5822 | ||||
IC50 | 8.92 | Bioorg. Med. Chem. Lett., (1998) 8:20:2871 | ||||
IC50 | 8.92 | J Med Chem, (2018) 61:14:5822 | ||||
Ki | 8.7 | Bioorg. Med. Chem. Lett., (1994) 4:19:2327 | ||||
IC50 | 8.7 | J. Med. Chem., (2005) 48:8:2972 | ||||
SRD5A1
3-oxo-5-alpha-steroid 4-dehydrogenase 1
25 Activities
Items per page:
1 – 10 of 25
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 7.58 | J. Med. Chem., (1995) 38:7:1158 | ||||
IC50 | 7.4 | J. Med. Chem., (2000) 43:22:4266 | ||||
IC50 | 7.39 | J. Med. Chem., (2002) 45:16:3406 | ||||
IC50 | 7.28 | J. Med. Chem., (1995) 38:17:3189 | ||||
IC50 | 7.28 | J. Med. Chem., (1994) 37:23:3871 | ||||
IC50 | 7.28 | J Med Chem, (2018) 61:14:5822 | ||||
IC50 | 7.22 | J. Med. Chem., (2005) 48:8:2972 | ||||
IC50 | 7.21 | J. Med. Chem., (1993) 36:3:421 | ||||
Ki | 7 | Bioorg. Med. Chem. Lett., (1994) 4:19:2327 | ||||
IC50 | 6.82 | J. Med. Chem., (1993) 36:26:4313 | ||||
CYP2C19
Cytochrome P450 2C19
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 6 | None, None:None:None | ||||